Hacker News
- CVS just announced a cheap generic alternative to the EpiPen http://arstechnica.com/science/2017/01/cvs-just-announced-a-super-cheap-generic-alternative-to-epipen 99 comments
- CVS just announced a super cheap generic alternative to EpiPen http://arstechnica.com/science/2017/01/cvs-just-announced-a-super-cheap-generic-alternative-to-epipen/ 3 comments technews
Linking pages
- Despite what Mylan said, its price hikes hit patients’ wallets hard | Ars Technica https://arstechnica.com/science/2017/03/despite-what-mylan-said-its-price-hikes-hit-patients-wallets-hard/ 10 comments
- Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica https://arstechnica.com/science/2017/06/mylan-chairman-drug-pricing-critics-ought-to-go-copulate-with-themselves/ 7 comments
- Years after Mylan’s epic EpiPen price hikes, it finally gets a generic rival | Ars Technica https://arstechnica.com/science/2018/08/fda-approves-generic-version-of-mylans-600-epipens-but-the-price-is-tbd/ 0 comments
- Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M | Ars Technica https://arstechnica.com/science/2017/05/amid-outrage-and-tumbling-stocks-mylans-chairman-pocketed-97m/ 0 comments
- After almost five months, Android 7.0 Nougat arrives on the Galaxy S7 | Ars Technica http://arstechnica.com/gadgets/2017/01/after-almost-five-months-android-7-0-nougat-arrives-on-the-galaxy-s7/ 0 comments
Linked pages
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 197 comments
- For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica http://arstechnica.com/science/2016/10/for-ripping-off-medicaid-epipen-maker-mylan-pays-feds-465-million/ 6 comments
- EpiPen maker CEO to seething lawmakers: We’re doing the world a favor | Ars Technica http://arstechnica.com/science/2016/09/epipen-maker-ceo-to-seething-lawmakers-were-doing-the-world-a-favor/ 6 comments
- EpiPen maker Mylan may have used illegal deals with schools to price gouge | Ars Technica http://arstechnica.com/science/2016/09/epipen-maker-mylan-may-have-used-illegal-deals-with-schools-to-price-gouge/ 3 comments
- Cigna is no longer covering the pricey EpiPen http://money.cnn.com/2017/01/11/news/cigna-drops-mylan-epipen/index.html 0 comments
- After almost five months, Android 7.0 Nougat arrives on the Galaxy S7 | Ars Technica http://arstechnica.com/gadgets/2017/01/after-almost-five-months-android-7-0-nougat-arrives-on-the-galaxy-s7/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: CVS just announced a super cheap generic alternative to EpiPen | Ars Technica
See how to search.